(Q36711602)

English

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

scientific article published on October 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

0 references

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

viral hepatitis

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

N Bindslev

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

E Christensen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

P Schlichting

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

S Schalm

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

V Carreno

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

C Trepo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

G Gerken

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

H C Thomas

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 October 1994

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Journal of Hepatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

646-655

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Persistent infection of humans with hepatitis B virus: mechanisms and consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered natural history of hepatitis B in homosexual males--a reflection of altered immune responsiveness?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dane Particles, DNA Polymerase, and e-Antigen in Two Different Categories of Hepatitis B Antigen Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus DNA, HBeAg and delta infection during the course from acute to chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon therapy for chronic type B hepatitis: the promise comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Eurohep. A European Community sponsored concerted action on viral hepatitis: its rationale and execution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblastoid interferon therapy of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(94)80114-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7814812%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36711602&oldid=1590410255"